Inventera Inc. logo

Inventera Inc. (0007J0)

Market Open
15 Oct, 06:30 AM
KRX SM KRX SM
₩
8,260. 00
-410
-4.729%
₩
68.98B Market Cap
- P/E Ratio
- Div Yield
43,893 Volume
- Eps
₩ 8,670
Previous Close
Add Transaction
Day Range
8,000 8,520
Year Range
6,090 60,200
Want to track 0007J0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

0007J0 trading today lower at ₩8,260, a decrease of -4.729% from yesterday's close, completing a monthly decrease of -25.1133% or -₩2,770. Over the past 12 months, 0007J0 stock lost -78.9017%.
0007J0 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

0007J0 Chart

Inventera Inc. (0007J0) FAQ

What is the stock price today?

The current price is ₩8,260.00.

On which exchange is it traded?

Inventera Inc. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 0007J0.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 68.98B.

Has Inventera Inc. ever had a stock split?

No, there has never been a stock split.

Inventera Inc. Profile

- Industry
- Sector
Mr. Tae-Hyun Shin CEO
KRX SM Exchange
- ISIN
South Korea Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Inventera Inc. is a pioneering biotechnology company dedicated to enhancing medical imaging through the development of advanced MRI contrast agents. With expertise in nanoparticle-based platforms, the company aims to significantly improve the resolution and safety of magnetic resonance imaging (MRI) procedures. Inventera focuses on creating targeted contrast agents tailored for specific applications within the medical field, such as the articular system, lymphatic vessels, and the pancreatic and biliary systems. Positioned within the pharmaceutical and biotech sector, Inventera Inc. is deeply committed to advancing diagnostic imaging technologies. Established in South Korea, the company plays a vital role in the evolution of precision medicine by producing safer, more effective imaging solutions for healthcare providers and patients around the globe.

Products and Services

  • Nanoparticle-based MRI Contrast Agents

    These agents are designed to enhance the clarity and precision of MRI scans, allowing for improved visualization of tissues and organs. By utilizing cutting-edge nanoparticle technology, Inventera’s contrast agents help provide a detailed understanding of various medical conditions, facilitating better diagnosis and treatment planning.

  • Targeted Contrast Agents

    Inventera develops specialized contrast agents that are specifically formulated for targeted applications. These include agents focusing on the articular system, lymphatic vessels, and the pancreatic and biliary systems, enhancing the imaging quality for specific anatomical areas and clinical needs.

  • Innovative Nanomaterials

    The company is at the forefront of research in innovative nanomaterials that contribute to the effectiveness of medical diagnostics. These materials are designed to provide superior performance, improving the sensitivity and specificity of imaging techniques.

  • Research and Development

    Inventera is actively involved in R&D activities aimed at creating next-generation imaging agents. This includes not only advancing current products but also exploring novel applications and technologies that can further enhance the capabilities of diagnostic imaging.

  • Collaboration with Healthcare Providers

    Inventera works closely with healthcare institutions to ensure that its products meet the needs of medical professionals and enhance patient care. This collaboration allows for the practical application of its innovations in real-world scenarios, ensuring the safety and efficacy of its imaging solutions.

Contact Information

Address: 2F
Phone: 82 2 533 1102